Rare Disease Revenue: $8.8 billion in 2024, up 16%. AstraZeneca PLC (NASDAQ:AZN) reported a strong financial performance in 2024, with total revenue up 21% and core EPS up 19%, indicating robust ...
Welcome, ladies and gentlemen, to AstraZeneca's full-year and Q4 2024 results conference call for investors and analysts. Before I hand over to AstraZeneca, I'd like to read the safe harbor statement.
AstraZeneca on Thursday said it could face a fine of up to $4.5 million in China over suspected unpaid import taxes, raising ...
Dave Fredrickson, Executive Vice President, Oncology Haematology Business Unit, AstraZeneca, said, "With this first approval of Datroway in the US, we continue to deliver on our ambition for ...
A targeted cancer therapy from AstraZeneca’s alliance with Daiichi ... for the treatment of multiple cancers,” Dave Fredrickson, executive vice president, oncology hematology business unit ...
BioPharmaceuticals Revenue: $21.9 billion in 2024, up 21%. Rare Disease Revenue: $8.8 billion in 2024, up 16%. AstraZeneca PLC (NASDAQ:AZN) reported a strong financial performance in 2024, with total ...
Michael Buckner/Variety/Penske Media via Getty David Lynch's cause of death has been revealed. Nearly a month after the beloved Twin Peaks director died at the age of 78, a death certificate ...
Amgen’s Lumakras and AstraZeneca’s Calquence are both in ... as a backbone therapy across multiple blood cancers,” Dave Fredrickson, executive vice president of AZ’s oncology hematology ...
David Lynch, who co-created “Twin Peaks” and directed films such as “Blue Velvet” and “Mulholland Drive,” has died. He was 78. Lynch’s family revealed his passing via social media on ...
Steven Spielberg, Ron Howard and more have paid tribute to David Lynch, the visionary director behind “Twin Peaks” and “Blue Velvet” who died at 78 years old. “I loved David’s films.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results